期刊文献+

Severe liver injury and clinical characteristics of occupational exposure to 2-amino-5-chloro-N,3-dimethylbenzamide: A case series

下载PDF
导出
摘要 Background:The 2-amino-5-chloro-N,3-dimethylbenzamide is a key intermediate in the synthesis of pesticides and pharmaceuticals.However,no literature currently exists on 2-amino-5-chloro-N,3-dimethylbenzamide poisoning in humans.This study aimed to reveal the health hazard of this chemical for humans and summarize the clinical characteristics of patients with occupational 2-amino-5-chloro-N,3-dimethylbenzamide poisoning.Methods:This observational study included four patients with 2-amino-5-chloro-N,3-dimethylbenzamide poisoning from June 2022 to July 2022.The entire course of the incidents was described in detail.Blood 2-amino-5-chloro-N,3-dimethylbenzamide concentrations were detected by a mass spectrometer.Hema-toxylin and eosin staining was performed to assess liver injury,and immunofluorescence was used to evaluate hepatic mitophagy.Results:The 2-amino-5-chloro-N,3-dimethylbenzamide powder(99%purity)entered the human body mainly via the skin and respiratory tract due to poor personal protective measures.The typical course of 2-amino-5-chloro-N,3-dimethylbenzamide poisoning was divided into latency,rash,fever,organic dam-age,and recovery phases in accordance with the clinical evolution.Rash and fever may be the important premonitory symptoms for further organ injuries.The chemical was detected in the blood of all patients and caused multiple organ injuries,predominantly liver injury,including kidney,myocardium,and micro-circulation.Three patients recovered smoothly after comprehensive treatments,including artificial liver therapy,continuous renal replacement therapy,glucocorticoids,and other symptomatic and supportive treatments.One patient survived by liver transplantation.The postoperative pathological findings of the removed liver showed acute liver failure,and immunofluorescence staining confirmed the abundance of mitophagy in residual hepatocytes.Conclusions:This study is the first to elaborate the clinical characteristics of patients with 2-amino-5-chloro-N,3-dimethylbenzamide poisoning.The chemical enters the body through the respiratory tract and skin during industrial production.The 2-amino-5-chloro-N,3-dimethylbenzamide poisoning causes multiple-organ dysfunction with a predominance of liver injury.Liver transplantation may be an effective option for patients with severe liver failure.The mechanisms of liver injury induced by 2-amino-5-chloro-N,3-dimethylbenzamide might involve abnormal mitochondrial function and mitophagy.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2024年第2期186-194,共9页 国际肝胆胰疾病杂志(英文版)
基金 This work was supported by grants from the Key Research and Development Program of Zhejiang Province(2019C03076) the Fundamental Research Funds for the Central Universities(226-2022-00088).
  • 相关文献

参考文献6

二级参考文献72

  • 1[1]Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease.Gastroenterology 2002; 122:1649-1657
  • 2[2]Franzese A,Vajro P,Argenziano A,Puzziello A,Iannucci MP,Saviano MC,Brunetti F,Rubino A.Liver involvement in obese children.Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.Dig Dis Sci 1997; 42:1428-1432
  • 3[3]Tominaga K,Kurata JH,Chen YK,Fujimoto E,Miyagawa S,Abe 1,Kusano Y.Prevalence of fatty liver in Japanese children and relationship to obesity.An epidemiological ultrasonographic survey.Dig Dis Sci 1995; 40:2002-2009
  • 4[4]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Horton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 5[5]Neuschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome.Am J Med Sci 2005; 330:326-335
  • 6[6]Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,Angulo P.The natural history of nonalcoholic fatty liver disease:a population-based cohort study.Gastroenterology 2005; 129:113-121
  • 7[7]Browning JD,Horton JD.Molecular mediators of hepatic steatosis and liver injury.J Clin Invest 2004; 114:147-152
  • 8[8]Machado M,Cortez-Pinto H.Non-alcoholic steatohepatitis and metabolic syndrome.Curr Opin Clin Nutr Metab Care 2006; 9:637-642
  • 9[9]Seppala-Lindroos A,Vehkavaara S,Hakkinen AM,Goto T,Westerbacka J,Sovijarvi A,Halavaara J,Yki-Jarvinen H.Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.J Clin Endocrinol Metab 2002; 87:3023-3028
  • 10[10]Loria P,Lonardo A,Carulli N.Should nonalcoholic fatty liver disease be renamed? Dig Dis 2005; 23:72-82

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部